explore -WSS

explore

author：explore 2025-10-01 01:50:53 - browse：7483

Illustration of a hospital bed with a spotlight above and money below. -- health tech coverage from STAT — Adobe

General Catalyst’s plan to take over a hospital in the coming months could be the first of many such deals, driven by financially strained hospitals looking for saviors, and venture capitalists convinced that they have the technology solutions for fixing the health care sector’s vexing problems.

The venture firm announced plans in October to acquire a health system and then use it as a proving ground for technology that its portfolio companies sell, including generative artificial intelligence-powered solutions applied to health care problems. The move — a result of industry-wide frustration with health systems’ risk aversion and hesitation to adopt new technology — also comes at a time when health tech startups that raised millions of venture dollars during the pandemic’s early stages are now scrambling to find customers.

Given workforce shortages, clinician burnout, rising drug costs, and a surging aging population, “it’s not that big a leap to say that more such purchases are going to occur,” said Robert Klitzman, a Columbia psychiatry professor and director of its bioethics masters program. “Hospitals are in a very tough spot,” he said, adding, “There may be hospitals that think, ‘Oh, great, someone wants to buy us.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Harvard's David Sinclair gets blowback over aging

entertainment

WSS

FDA proposes changes to key medical devices approval pathway

Why Talkspace is targeting Medicare, a tricky market

$1 billion proposal to grow Boston, Massachusetts biotech

First over

Change Healthcare: What is it, why does its cyberattack matter?

Walmart eyes Medicare Advantage provider ChenMed

Wikipedia

explore

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

As demand for Covid shots wanes, Moderna seeks its next success

Acelyrin, a rare IPO success, stumbles in its first big test

Peter Hotez and the public health issue of online harassment

Diverse clinical trials: Why aren’t we there yet?

New air purifier tech could be key to improving indoor air quality

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Heart attack and stroke risk calculators need revising

Harvard's David Sinclair gets blowback over aging

explore

IVF doctors demand details after CooperSurgical lawsuit

Regeneron agrees to White House price limits on anti

Long Covid needs a new name — and a new frame

For AI in health care standards, federal regulators join with industry group

New weight loss drugs vying to be the next Wegovy or Mounjaro

FDA approves updated Covid vaccines

entertainment

hotspot

leisure time

Wikipedia